Stents Peripheral

Peripheral stents are used to open narrow and hardening arteries that supply blood to the legs and feet.

Endovascular-first Approach Equal to Open Surgery in Avoiding Amputation for Critical Limb Ischemia

August 1, 2019 — Less-invasive procedures to open severely clogged leg arteries were as good at helping people survive ...

August 01, 2019

Intact Vascular Inc. received U.S. Food and Drug Administration (FDA) market clearance for the Tack Endovascular System. This is a purpose-built dissection repair device implanted post-angioplasty in patients with peripheral arterial disease (PAD).

Technology | Peripheral Artery Disease (PAD)

FDA Clears Intact Vascular’s Tack Endovascular System

April 15, 2019 – Intact Vascular Inc. received U.S. Food and Drug Administration (FDA) market clearance for the Tack ...

April 15, 2019

The Boston Scientific Eluvia self-expanding, drug-eluting peripheral stent. It outperformed the Cook Zilver stent in the IMPERIAL Trial presented at TCT 2018.

Feature | Peripheral Artery Disease (PAD) | Dave Fornell, Editor

New Peripheral Stent Technology

In recent years, there has been a lot of focus by vendors on developing better stenting technologies to treat peripheral ...

January 30, 2019

The safety of paclitaxel-eluting stents and drug-coated balloons was called into question in a recent study that showed higher mortality rates after two years. The Cook Zilver PTX paclitaxel-eluting peripheral stent is among the devices included in that study.

Feature | Peripheral Artery Disease (PAD) | Dave Fornell, Editor

Safety of Paclitaxel-eluting Stents and Balloons Called Into Question

The anti-proliferative drug paclitaxel has been used as a coating on coronary stents to prevent restenosis since 2003 ...

January 25, 2019

News | Peripheral Artery Disease (PAD)

FDA Issues Letter About Paclitaxel Coated Balloons and Eluting Stents

January 17, 2019 — The U.S. Food and Drug Administration (FDA) issued a letter Jan. 17, 2019, to healthcare providers ...

January 17, 2019

Videos

VIDEO: Boston Scientific's Recent Cardiology Advances and Technology Acquisitions

Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston Scientific ...

October 11, 2018

Technology | Stents Peripheral

Veryan Medical's BioMimics 3D Stent Receives PMA Approval

October 5, 2018 — Veryan Medical Ltd has received Premarket Approval (PMA) for the BioMimics 3D Vascular Stent System ...

October 05, 2018

News | Peripheral Artery Disease (PAD)

SCAI Releases Consensus Guidelines for Femoral-Popliteal Arterial Interventional Device Selection

May 15, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to ...

May 15, 2018

News | Stents Peripheral

Intact Vascular Announces $20 Million Series C Financing

April 27, 2018 — Intact Vascular Inc. recently closed a Series C financing totaling $20 million. This financing is ...

April 27, 2018

News | Cardiovascular Clinical Studies

12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC

February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS-2 ...

February 01, 2018

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab

VIVA 2017 Late-breaking Clinical Trial Presentations

September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials ...

September 14, 2017

News | Stents Peripheral

First European Patient Enrolled in Intact Vascular's TOBA II BTK Trial

July 26, 2017 — Intact Vascular Inc. recently announced that its Tack Optimized Balloon Angioplasty II Below the Knee ...

July 26, 2017

News | Peripheral Artery Disease (PAD)

First Patient Treated in U.S. Feasibility Study of LimFlow Critical Limb Ischemia Device

July 17, 2017 — LimFlow SA announced enrollment of the first patient in the U.S. feasibility study of the LimFlow ...

July 17, 2017

News | Stents Peripheral

FDA Approves Six-Month Primary Endpoint for Tack Endovascular System in Below the Knee Disease

July 14, 2017 — Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational ...

July 14, 2017

News | Stents Peripheral

New Twelve-Month Data Show Efficacy of Pulsar-18 Bare Metal Stent

April 28, 2017 — Biotronik’s Pulsar-18 bare metal stent (BMS) has yielded high primary patency in a real-world setting ...

April 28, 2017